cryptogamefi| CITIC Construction Investment: Some results of the 2024 ASCO Conference have been released, and the progress of domestic innovative pharmaceutical companies deserves attention

Gelonghui May 26| CITIC construction investment pointed outcryptogamefi, at the 2024 ASCO Conferencecryptogamefi, many domestic innovative pharmaceutical companies have released the latest research results of their clinical trials. Overall, the oncology drug forms of China's innovative pharmaceutical companies cover monoclonal antibodies, dual antibodies and ADCs. The product design is innovative and the clinical trial results are equally excellent, demonstrating good clinical effects in the treatment of various tumors. We believe that China's innovative pharmaceutical companies continue to make efforts on the oncology track, and many products have demonstrated the potential of BIC in oncology indications. More subsequent clinical results are worthy of attention.